{
    "organizations": [],
    "uuid": "3a8c1884bdad01c479e19d1600c5923185e71884",
    "author": "",
    "url": "https://www.reuters.com/article/brief-savara-initiates-phase-2a-clinical/brief-savara-initiates-phase-2a-clinical-study-of-molgradex-for-the-treatment-of-ntm-lung-infection-idUSFWN1QV0IR",
    "ord_in_thread": 0,
    "title": "BRIEF-Savara Initiates Phase 2A Clinical Study Of Molgradex For The Treatment Of Ntm Lung Infection",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 03 PM / Updated 12 minutes ago BRIEF-Savara Initiates Phase 2A Clinical Study Of Molgradex For The Treatment Of Ntm Lung Infection Reuters Staff 1 Min Read March 13 (Reuters) - Savara Inc: * SAVARA INITIATES PHASE 2A CLINICAL STUDY OF MOLGRADEX FOR THE TREATMENT OF NTM LUNG INFECTION Source text for Eikon: Further company coverage:",
    "published": "2018-03-13T14:02:00.000+02:00",
    "crawled": "2018-03-13T14:22:53.086+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "initiate",
        "phase",
        "2a",
        "clinical",
        "study",
        "molgradex",
        "treatment",
        "ntm",
        "lung",
        "infection",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "savara",
        "inc",
        "savara",
        "initiate",
        "phase",
        "2a",
        "clinical",
        "study",
        "molgradex",
        "treatment",
        "ntm",
        "lung",
        "infection",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}